Evidence map›Paper›PMID 42182962›Full record

ArticlePhysics and imaging in radiation oncology2026

Photon-counting detector computing tomography in treatment planning of head-and-neck cancer.

Enkelejda Lamaj, Patrick Wohlfahrt, Lotte Wilke, Hatem Alkadhi, Niccolo Bertini, Hubert Gabrys, Matthias Guckenberger, Panagiotis Balermpas, Stephanie Tanadini-Lang, Serena Psoroulas

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Enkelejda LamajDepartment of Radiation Oncology, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.
Patrick WohlfahrtSiemens Healthineers, Cancer Therapy Imaging, Forchheim, Germany.
Lotte WilkeDepartment of Radiation Oncology, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.
Hatem AlkadhiDiagnostic and Interventional Radiology, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.
Niccolo BertiniDepartment of Radiation Oncology, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.
Hubert GabrysDepartment of Radiation Oncology, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.
Matthias GuckenbergerDepartment of Radiation Oncology, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.
Panagiotis BalermpasDepartment of Radiation Oncology, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.
Stephanie Tanadini-LangDepartment of Radiation Oncology, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.
Serena PsoroulasDepartment of Radiation Oncology, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Photon-counting detector computed tomography (PCD-CT) offers several image reconstruction options, e.g. virtual monoenergetic images (VMIs) and relative electron density (RED) images. This study investigated these PCD-CT reconstructions for dose calculation in head-and-neck cancer (HNC) patients. Materials and methods: 10 HNC patients referred to radiotherapy were scanned with PCD-CT. The same contouring and therapy strategy was followed as in the patients' clinical treatment, optimized on an energy-integrated-detector CT (EID-CT). 18 volumetric arc therapy treatment plans (6 MV photons) were optimized on RED images and recalculated on 70 keV VMI (VMI70), using the same amount of monitor units. While RED images did not require scanner-specific calibration, the conversion from CT number to RED for VMI70 was calibrated using a phantom with tissue-equivalent inserts with known RED. To assess the clinical impact of using RED maps with vendor-provided calibration, one plan per patient was recalculated using bulk material overrides. Plan quality was evaluated by evaluating dose-volume metrics, such as the dose to 98% of planning target volume, and compared between RED, VMI70, and EID-CT. Results: All plans optimized on RED images fulfilled the clinical goals. Dose-volume metrics differed by <3% between RED and VMI70 and <5% between RED and EID-CT. RED differed by differed by <4% from bulk density override (<1% when the target did not overlap with air volumes). Conclusions: Treatment planning can be accurately performed on PCD-CT images of HNC cases, using either VMI (after CT-number-to-RED conversion) or RED images (without scanner-specific calibration).

Indexed as

Computer tomographyHead and neck cancerMetal artifact reductionPhoton-counting detectors

Identifiers

PMID42182962
PMCPMC13196142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.